On Wednesday, Shares of Barrick Gold Corporation (USA) (NYSE:ABX), gained 2.42% to $6.36.
Barrick Gold Corporation declared that it and certain of its auxiliaries have commenced a cash tender offer for specified series of outstanding notes. The terms and conditions of the Tender Offer are described in an offer to purchase and the related letter of transmittal (the “Letter of Transmittal”), each dated recently.
Barrick Gold Corporation (Barrick) is a gold mining company. The Company is engaged in the production and sale of gold and copper, as well as related activities, such as exploration and mine development. The Company operates in segments: eight individual gold mines, Acacia and Pascua-Lama project.
Shares of AbbVie Inc (NYSE:ABBV), inclined 3.07% to $54.41, during its last trading session.
AbbVie declared that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved VIEKIRAX® (ombitasvir/paritaprevir/ritonavir), as a new interferon and ribavirin-free treatment option for adult patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, counting those with compensated liver cirrhosis. VIEKIRAX comprises of a 12-week, two direct-acting antiviral, fixed-dose combination of paritaprevir/ritonavir with ombitasvir, dosed once daily.
“Today’s approval represents an important step forward for the treatment of Japanese patients, a population with specific needs based on patient and viral characteristics,” said Jean-Michel Pawlotsky, MD, PhD, professor of medicine at the University of Paris-Est, France. “VIEKIRAX is a valuable new addition to a number of treatments that are changing the face of hepatitis C, making it possible to achieve high virologic cure rates, even in patients whose disease has progressed to compensated liver cirrhosis.”
Japan has one of the highest rates of hepatitis C infection in the industrialized world, with about 1.5 to 2 million people living with HCV. Genotype 1 is the most common HCV genotype in Japan with 60 to 70 percent of patients infected and, of those, about 95 percent are infected with the genotype 1b (GT1b) sub-type.
AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases. The Company’s products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn’s disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson’s disease; complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone.
Shares of Texas Instruments Incorporated (NASDAQ:TXN), inclined 4.19% to $49.52, during its last trading session.
Texas Instruments Incorporated introduced a new family of clock generators that provides ultra-low jitter of 100 femtoseconds (fs) and flexible, unique pin control options. Contrast to conventional reference clock solutions, the new clock generators’ jitter performance enables system designers to optimize system timing margins and bit error rate (BER) to reduce data transmission errors. This allows for more reliable communications, networking, server, computing, and high-performance industrial equipment. LMK033x8 clock generators also offer versatile features to reduce design cycle time by facilitating easy prototype design and evaluation.
Key features and benefits of LMK033x8 clock generators
- Ultra-low jitter performance enables flexible jitter budgeting: Up to two high-performance PLLatinum™ fractional-N phase-locked loops (PLLs) with eight outputs enable ultra-low jitter performance of 100 fs root mean square (RMS) over multiple integration bandwidths (1 KHz-5 MHz and 12 KHz-20 MHz). Designers can take advantage of the ultra-low jitter to improve their system BER and improvement the reliability of their telecommunications infrastructure equipment.
- Flexible, simple configuration: A unique pin-mode control feature enables designers to easily select from 71 pre-programmed frequency startup plans contrast to one-time programmable memory offered by competitors. Integrated electrically erasable programmable read-only memory (EEPROM) enables easy customization, while the I2C interface gives system designers complete control of device configuration.
- Reduced design cycle time: Glitchless fine/coarse frequency margining enables designers to simplify the stress and compliance testing of their systems during design verification and process verification (DVT/PVT) of prototypes.
- Immune to supply noise: Integrated low-dropout regulators (LDOs) provide immunity to power-supply noise without requiring complex filter designs.
Texas Instruments Incorporated designs, makes and sells semiconductors to electronics designers and manufacturers across the world. The Company operates through two segments: Analog and Embedded Processing.
Finally, ARM Holdings plc (ADR) (NASDAQ:ARMH), ended its last trade with 2.83% gain, and closed at $43.25.
Microsoft has certified the ARM® mbed Enabled™ Freescale® FRDM-K64F development board for Internet of Things (IoT) products that securely gather and channel data into the public cloud platform, Microsoft Azure. This is the first ARM mbed™ board tested and verified by MicrosoftAzure Certified for IoT to support the Microsoft Azure IoT Suite. Microsoft Azure is an open, flexible and trusted cloud platform used by the majority of Fortune 500 companies.
Developers using the ARM Cortex®-M4 based FRDM-K64F board will have access and guided instructions to the Microsoft Azure IoT Suite software development kits (SDK) published on Github. The libraries have been tested on the board and can be used with mbed applications through the mbed developer website to enable direct connectivity with Azure IoT Suite.
“The partnership with Microsoft is testament to the growing influence of the ARM mbed IoT Device Platform,” said Krisztian Flautner, general manager, IoT business, ARM. “Recently’s certification of the mbed Enabled Freescale FRDM-K64F board links our technology directly into Microsoft’s public cloud platform. The connection into a powerful analytics platform will allow product developers to offer valuable new big data services at scale.”
ARM Holdings plc (ARM) is a United Kingdom-based company engaged in designing of microprocessors, physical intellectual property (IP) and related technology and software, and sale of development tools. The Company’s offers products, such as 16/32/64-bit RISC microprocessors, data engines, graphics processors, digital libraries, embedded memories, peripherals, software and development tools, as well as analog functions and high-speed connectivity products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
